Clinical results of XEN gel stent implant in minimally invasive combined glaucoma and cataract surgery
Session Details
Session Title: Presented Poster Session: FLACS & Others
Venue: Poster Village: Pod 1
First Author: : A.De Gregorio ITALY
Co Author(s): : L. Russo M. Montali G. Stevan S. Morselli
Abstract Details
Purpose:
To verify the efficacy in intraocular pressure (IOP) reduction and safety of the smallest gel stent (XEN 45 Gel Stent) microincisional glaucoma surgery (MIGS) combined with microincisional cataract surgery (MICS).
Setting:
San Bassiano Hospital, Bassano del Grappa, Italy
Methods:
Non-randomized prospective clinical study. Forty-one eyes of 33 patients with open-angle glaucoma (OAG) underwent a XEN 45 gel stent implantation combined with MICS. Treatment outcomes analyzed included IOP, medication use, intra e postoperative complications. At the end of the follow-up we evaluated the complete success, defined as a postoperative IOP ≥ 6 mmHg and ≤ 17 mmHg without glaucoma medications and the qualified success defined as a post-operative IOP ≥ 6 mmHg and ≤ 17 mmHg , with glaucoma medications.
Results:
The mean preoperative IOP was 22.5 ± 3.7 mmHg on 2.5 ± 0.9 medication classes. After 12 months the mean postoperative IOP was 13.1 ± 2.4 mmHg (mean IOP reduction of 41.82%) with a mean of 0.4 ± 0.8 medication classes (P < 0.05 for IOP and medications). The complete success rate was achieved in 80.4% and a qualified success in 97.5%. No major intra and postoperative complications during the first year of follow-up.
Conclusions:
This study demonstrated that the smaller diameter XEN 45 gel implant is statistically effective in reducing IOP and medications in glaucoma patients with a low rate of complications.
Financial Disclosure:
NONE
